* Hyperfine Inc HYPR.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -19
cents. The mean expectation of three analysts for the quarter
was for a loss of 18 cents per share. Wall Street expected
results to range from -20 cents to -16 cents per share.
* Revenue rose 88.6% to $2.69 million from a year ago;
analysts
expected $3.71 million.
* Hyperfine Inc's reported EPS for the quarter was a loss
of 15
cents.
* The company reported a quarterly loss of $10.68 million.
* Hyperfine Inc shares had risen by 2.7% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Hyperfine Inc is
$1.70
This summary was machine generated from LSEG data March 21 at
09:43 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.18 -0.15 Beat
Sep. 30 2023 -0.16 -0.15 Beat
Jun. 30 2023 -0.16 -0.15 Beat
Mar. 31 2023 -0.13 -0.17 Missed